Antimicrobial agent-21

CAS No. 724746-07-0

Antimicrobial agent-21( —— )

Catalog No. M36100 CAS No. 724746-07-0

Antimicrobial agent-21 is a potent mitogen activated protein kinase inhibitor with antibacterial, anti-inflammatory and antitumor activity for the treatment of cataracts, ulcerative colitis, meningitis and Kawasaki's disease and Parkinson's disease.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 187 In Stock
5MG 282 In Stock
10MG 430 In Stock
25MG 674 In Stock
50MG 908 In Stock
100MG 1215 In Stock
500MG 2448 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Antimicrobial agent-21
  • Note
    Research use only, not for human use.
  • Brief Description
    Antimicrobial agent-21 is a potent mitogen activated protein kinase inhibitor with antibacterial, anti-inflammatory and antitumor activity for the treatment of cataracts, ulcerative colitis, meningitis and Kawasaki's disease and Parkinson's disease.
  • Description
    Antimicrobial agent-21 (Compound IIm) is a bacterial inhibitor. Antimicrobial agent-21 is active against gram-positive and gram-negative bacterial.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    MAPK/ERK Signaling
  • Target
    p38 MAPK
  • Recptor
    MAPK
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    724746-07-0
  • Formula Weight
    319.38
  • Molecular Formula
    C18H13N3OS
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C1C=2C(=C(C)SC2NC(=N1)C3=CC=CC=N3)C4=CC=CC=C4
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. NITIN G. HASWANI,et al. Synthesis and antimicrobial activity of novel 2-(pyridin-2-yl)thieno[2,3-d]pyrimidin-4 (3H)-ones. Turkish Journal of Chemistry. 2011, 35 (6), 915–924.
molnova catalog
related products
  • SKLB-163

    SKLB-163 acts by downregulating RhoGDI, activating JNK-1 signaling pathway and caspase-3, and reducing phosphorylated Akt and p44/42 MAPK.

  • HPK1-IN-7

    HPK1-IN-7 is an orally active HPK1 inhibitor. It shows selectivity against IRAK4 (59 nM) and GLK (140 nM).

  • p38α inhibitor 3

    p38α inhibitor 3 is a inhibitor of the mitogen-activated protein kinase p38α that can block the effectiveness of myoblast differentiation.